查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1198494

听诊器市场 - 增长、趋势、COVID-19 影响和预测 (2023-2028)

Stethoscope Market - Growth, Trends, and Forecasts (2023 - 2028)
出版日期: | 出版商: Mordor Intelligence | 英文 130 Pages | 商品交期: 2-3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

在预测期内（2022 年至 2027 年），听诊器市场预计将以 4.5% 的复合年增长率增长。

由于感染的传播和与患者的直接接触，COVID-19 爆发对市场的影响很大。 然而，随着COVID-19的爆发，传染病控制意识的提高，必须逻辑地权衡听诊器的好处和风险。 听诊器广泛用于各种医疗行业，例如护士和呼吸治疗师。 听诊器是最常用的听肠音、肺音和心音的仪器。 然而，儘管使用频率很高，但听诊器的诊断准确性有限。 一篇题为“关于 COVID-19 听诊器的辩论”的论文。 在 2021 年 2 月发表的文章“必要的工具或不必要的邪恶”中，许多研究报告了对可能成为感染媒介的听诊器的担忧。 即使在对患者进行一次身体检查后，听诊器污染也很严重。 污染风险最高的是听诊器的隔膜区域。 因此，我们开发了一种用触摸式代替听诊器隔膜的分配器，以支持大流行后期的市场增长。 例如，2020年4月，印度理工学院孟买生物医学工程与技术创新中心（BETIC）开发了一款支持蓝牙的智能听诊器模块“AYU DEVICES”，DBT——印度政府生物技术产业研究援助委员会（BIRAC）支持 该设备允许临床医生和医护人员从安全距离听诊患者。 因此，疫情期间的这些发展对市场的增长产生了积极影响。

心血管和肺部疾病负担的增加、患者平均就诊次数的增加以及与设备相关的技术进步预计将在预测期内推动市场。 根据世界卫生组织 (WHO) 2021 年 7 月的更新，心血管疾病是全球死亡的主要原因。 其中包括冠心病、脑血管病、风湿性心脏病、先天性心脏病等疾病。 由于心血管疾病发病率的增加，由医院和诊断中心的专家进行的初步检查也在增加。 预计心血管疾病和相关并发症的高患病率将推动对听诊器的需求，扩大所研究市场的范围并促进其在预测期内的增长。

此外，预计人口老龄化将对调查市场产生重大影响，因为 65 岁及以上的人更容易患慢性病，定期检查的需求也会增加。 根据世界人口展望，2022年，全球65岁及以上人口将在2022年达到7.71亿，2030年达到9.94亿，2050年达到16亿。预测。 此外，根据美国疾病控制与预防中心 2022 年 2 月更新的数据，2020 年美国有 83.4% 的成年人接受过医生或其他医疗保健提供者的拜访。 美国有 8.604 亿患者，初级保健医生就诊率为 51.2%。 因此，预计在预测期内，增加平均就医次数也将推动市场。

此外，主要市场参与者采用的各种策略预计将在预测期内推动市场增长。 例如，2021 年 6 月，3M 和 Eko 联合推出了一款将 3M Littmann 技术与先进的 Eko 数字创新相结合的听诊器。 在英国和爱尔兰，3M Littmann 的听诊器 CORE 数字听诊器迅速成为医生的最爱。

因此，所有上述因素，例如医院和诊所的患者入院人数增加，心血管疾病预诊断增加，人口中与年龄相关的疾病等，预计将推高 然而，越来越多地采用先进的预检设备可能会阻碍市场增长。

听诊器市场趋势

电子听诊器领域有望占据听诊器市场的主要市场份额

在按类型划分的听诊器市场中，电子听诊器部分预计将占据很大的市场份额。 电子听诊器可以将通过胸件获得的声学声波转换为电信号并将其放大以获得最佳听诊效果。 此外，转换后的电信号被数字化，可以进一步处理和传输。 该细分市场的增长归因于慢性病负担的增加、技术进步和产品发布。

此外，市场参与者的技术进步和创新也在推动这一细分市场的增长。 例如，2022 年 5 月，3M Littmann 宣布其“2022 Fast Company World Changing Ideas”表彰支持为共同利益而创新并解决社会不平等、气候变化和公共卫生危机的公司、产品和举措。宣布 3M Littmann CORE 数字听诊器在世界奖项计划的健康类别中获得了荣誉奖。

此外，波兰远程医疗创新公司 StethoMe 在最近与欧洲领先的远程医疗提供商 MaQuestionMedicale 和 HomeDoctor 合作后，于 2020 年 4 月推出了人工智能无线听诊器。。 此类发布正在推动这一细分市场的增长。

因此，由于上述因素，市场有望在预测期内增长。

北美将在市场中占有重要地位，预计在预测期内也会如此

由于人口老龄化、慢性病负担增加、主要市场参与者的存在以及医院数量的增加，北美预计将在全球听诊器市场中占有重要的市场份额。

此外，该地区不断增长的老年人口也在推动市场的增长。 例如，根据加拿大统计局 2021 年的人口普查，65 岁及以上的人口大约有 7,021,430 人，其中男性 3,224,680 人，女性 3,796,750 人。 老年人最容易患上各种疾病，因此必须进行健康检查，从而推动整个医疗环境对听诊器的需求。

此外，主要市场参与者的各种关键战略（例如合作伙伴关係和併购）预计将提振该地区的市场。 例如，2022年4月，Sanolla向FDA（食品药品监督管理局）推出了具有AI功能的低频听诊器“VoqX”，供美国临床使用。 同样，2021 年 6 月，HD Medical 宣布其旗舰产品 HD Steth 现在可以通过听诊器和医疗产品的领先在线零售商 Stethoscope.com 在线购买。 HD Medical 最近将 Stethoscope.com 介绍为美国主要的在线分销合作伙伴。 此外，完善的医疗保健基础设施的存在也极大地推动了该地区整体市场的增长。

鑑于这些因素，预计市场在预测期内将会增长。

听诊器市场竞争对手分析

听诊器市场竞争适中，由几家大型企业组成。 从市场份额的角度来看，目前几家大型企业占据了市场主导地位。 目前主导市场的公司包括 3M、GF Health Products Inc.、Smiths Medical、Masimo Corporation 和 Medtronic plc。

其他好处

  • Excel 格式的市场预测 (ME) 表
  • 三个月的分析师支持

内容

第1章介绍

  • 研究假设和市场定义
  • 调查范围

第2章研究方法论

第 3 章执行摘要

第4章市场动态

  • 市场概览
  • 市场驱动因素
    • 增加心血管和肺部疾病的负担
    • 增加患者平均看医生的次数
  • 市场製约因素
    • 先进的预检测设备的采用正在取得进展
  • 波特的五力分析
    • 新进入者的威胁
    • 买方/消费者议价能力
    • 供应商的议价能力
    • 替代品的威胁
    • 竞争公司之间的敌对关係

第 5 章市场细分（基于价值的市场规模：100 万美元）

  • 按类型
    • 手动听诊器
    • 电子听诊器
  • 最终用户
    • 医院和诊所
    • 门诊手术中心
    • 家庭保健
  • 按地区
    • 北美
      • 美国
      • 加拿大
      • 墨西哥
    • 欧洲
      • 德国
      • 英国
      • 法国
      • 意大利
      • 西班牙
      • 其他欧洲地区
    • 亚太地区
      • 中国
      • 日本
      • 印度
      • 澳大利亚
      • 韩国
      • 其他亚太地区
    • 中东
      • 海湾合作委员会
      • 南非
      • 其他中东地区
    • 南美洲地区
      • 巴西
      • 阿根廷
      • 其他南美洲

第6章竞争格局

  • 公司简介
    • 3M
    • Welch Allyn
    • GF Health Products Inc.
    • Medline Industries Inc.
    • American Diagnostic Corporation
    • Rudolf Riester GmbH
    • Cardionics
    • Smiths Medical
    • Heine Optotechnik GmbH & Co. KG
    • Eko Devices
    • Meditech Equipment Co., Ltd.
    • Contec Medical Systems

第7章 市场机会与今后动向

简介目录
Product Code: 68955

The Stethoscope Market is projected to register a CAGR of 4.5% during the forecast period (2022-2027).

The impact of the COVID-19 outbreak on the market was substantial owing to growing infections and direct contact with the patients. However, the advantages of the stethoscope must be logically weighed against the risks, as COVID-19 has sparked an era of enhanced infection control awareness. The use of the stethoscope is extensive among various medical specialists, such as nurses and respiratory therapists. The device is most frequently used for the auscultation of intestinal, lung, and heart sounds. The stethoscope's diagnostic accuracy was constrained despite its ubiquitous usage. An article titled "Controversies on the Stethoscope During COVID-19: A Necessary Tool or an Unnecessary Evil" published in February 2021 reported that numerous studies have raised concerns regarding stethoscopes as potential infection vectors. Contamination of the stethoscope is significant even after a single physical exam of the patient. The most common area at risk of contamination is the diaphragm of the stethoscope. On the other hand, a touch-free stethoscope diaphragm dispenser might be a good fit for this requirement, hence the development of such devices boosted the growth of the market in the latter phase of the pandemic. For instance, in April 2020, a Bluetooth-enabled Smart Stethoscope Module "AYU DEVICES" was developed by the Biomedical Engineering and Technology Innovation Centre (BETIC), IIT Bombay, and was supported by the Biotechnology Industry Research Assistance Council (BIRAC), DBT-Government of India. The device allowed clinicians and medical practitioners to auscultate patients from a safe distance. Thus, such developments amid the outbreak had a positive impact on the market's growth.

The growing burden of cardiovascular and pulmonary diseases, the increase in average patient visits to physicians, and technological advancements associated with the instruments are expected to drive the market over the forecast period. According to the July 2021 update by the World Health Organization, cardiovascular diseases are the leading cause of death around the world. Some of these include diseases such as coronary heart disease, cerebrovascular disease, rheumatic heart disease, congenital heart disease, and others. The preliminary testing done by the professionals in hospitals and diagnostic centers is increasing due to the increasing incidence of cardiovascular diseases. The high prevalence of cardiovascular diseases and complications associated with them are expected to drive demand for stethoscopes, which will expand the scope of the market studied and boost its growth over the forecast period.

Additionally, the geriatric population is expected to have a significant impact on the market studied as people aged over 65 are more prone to chronic diseases that will drive the demand for regular check-ups. According to the World Population Prospect, 2022, globally, in 2022, there were 771 million people aged 65 years or over, and the number is projected to reach 994 million by 2030 and 1.6 billion by 2050. Moreover, according to the Centers for Disease Control and Prevention data updated in February 2022, the percentage of adults who had a visit with a doctor or other health care professional in the United States was 83.4% in 2020. The number of visits in the United States was 860.4 million, and the percentage of visits made to primary care physicians was 51.2%. Therefore, the increase in average patient visits to physicians is also expected to drive the market during the forecast period.

Furthermore, various strategies adopted by the key market players are anticipated to drive market growth over the forecast period. For instance, in June 2021, 3M and Eko collaborated to launch a stethoscope that combines 3M Littmann technology with advanced Eko digital innovations. In the United Kingdom and Ireland, the 3M Littmann stethoscope, the CORE Digital Stethoscope, quickly became a popular choice among physicians.

Thus, all the aforementioned factors, such as increasing patient admissions in hospitals and clinics, increasing preliminary diagnosis of cardiovascular diseases, and age-related disorders in the population, are expected to boost the stethoscope market over the forecast period. However, the growing adoption of advanced preliminary testing devices may hamper the growth of the market.

Stethoscope Market Trends

Electronic Stethoscope Segment is Expected to Hold a Major Market Share in the Stethoscope Market

The electronic stethoscope segment is projected to hold a significant market share in the stethoscope market by type. Electronic stethoscopes convert the acoustic sound waves obtained through the chest piece into electrical signals, which can then be amplified for optimal listening. The converted electrical signals can also be digitalized for further processing and transmission. The growth of this segment is attributed to the growing burden of chronic diseases, advancements in technology coupled with the launch of products in the market.

The advancement in technology and innovation by the market players is also propelling the growth of the segment. For instance, in May 2022, 3M Littmann reported that the 3M Littmann CORE Digital stethoscope received honorable mention accolades in the health category of the 2022 Fast Company World Changing Ideas global awards program, recognizing companies, products, and initiatives that support innovation for the public good and tackle social inequality, climate change, and public health crises.

Furthermore, in April 2020, Polish telemedicine innovations company StethoMe rolled out its artificial intelligence wireless stethoscope following recent collaborations with major telemedicine providers MaQuestionMedicale and HomeDoctor in Europe. Such launches are propelling the growth of the segment.

Thus, owing to the abovementioned factors, the market segment is expected to project growth over the forecast period.

North America is Expected to Hold a Significant Share in the Market and is Expected to do Same in the Forecast Period

North America is expected to hold a significant market share in the global stethoscope market, due to the increasing aging population, the rising burden of chronic diseases, the presence of major market players, and an increasing number of hospitals.

The growing geriatric population in the region is also propelling the growth of the market. For instance, as per the Statistics Canada 2021 census, there were around 7,021,430 people aged 65 years or above, out of which 3,224,680 were males and 3,796,750 were females. As the aged population is most vulnerable to various diseases, a health check-up has become mandatory, thereby driving the demand for stethoscopes across healthcare settings.

Furthermore, various key strategies by the key market players, such as partnerships, mergers, and acquisitions, are expected to boost the market in the region. For instance, in April 2022, Sanolla launched the AI-ready VoqX infrasound stethoscope with the Food and Drug Administration (FDA) for clinical usage in the United States. Similarly, HD Medical announced in June 2021 that its flagship product, HD Steth, is now available for purchase online through Stethoscope.com, one of the leading online stethoscope and medical product distributors. HD Medical recently introduced Stethoscope.com as a key online distribution partner in the United States. Furthermore, the presence of well-established healthcare infrastructure is also fueling the growth of the overall regional market to a large extent.

Thus, owing to the abovementioned factors, the market is expected to project growth over the forecast period.

Stethoscope Market Competitor Analysis

The stethoscope market is moderately competitive and consists of several major players. In terms of market share, a few of the major players are currently dominating the market. Some of the companies which are currently dominating the market are 3M, GF Health Products Inc., Smiths Medical, Masimo Corporation, and Medtronic plc, among others.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Growing Burden of Cardiovascular and Pulmonary Diseases
    • 4.2.2 Increase in Average Patient Visits to Physicians
  • 4.3 Market Restraints
    • 4.3.1 Growing Adoption of Advanced Preliminary Testing Devices
  • 4.4 Porter's Five Force Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION (Market Size by Value - USD million)

  • 5.1 By Type
    • 5.1.1 Manual Stethoscope
    • 5.1.2 Electronic Stethoscope
  • 5.2 By End Users
    • 5.2.1 Hospitals & Clinics
    • 5.2.2 Ambulatory Surgical Centers
    • 5.2.3 Home Healthcare
  • 5.3 Geography
    • 5.3.1 North America
      • 5.3.1.1 United States
      • 5.3.1.2 Canada
      • 5.3.1.3 Mexico
    • 5.3.2 Europe
      • 5.3.2.1 Germany
      • 5.3.2.2 United Kingdom
      • 5.3.2.3 France
      • 5.3.2.4 Italy
      • 5.3.2.5 Spain
      • 5.3.2.6 Rest of Europe
    • 5.3.3 Asia Pacific
      • 5.3.3.1 China
      • 5.3.3.2 Japan
      • 5.3.3.3 India
      • 5.3.3.4 Australia
      • 5.3.3.5 South Korea
      • 5.3.3.6 Rest of Asia-Pacific
    • 5.3.4 Middle East
      • 5.3.4.1 GCC
      • 5.3.4.2 South Africa
      • 5.3.4.3 Rest of Middle East
    • 5.3.5 South America
      • 5.3.5.1 Brazil
      • 5.3.5.2 Argentina
      • 5.3.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 3M
    • 6.1.2 Welch Allyn
    • 6.1.3 GF Health Products Inc.
    • 6.1.4 Medline Industries Inc.
    • 6.1.5 American Diagnostic Corporation
    • 6.1.6 Rudolf Riester GmbH
    • 6.1.7 Cardionics
    • 6.1.8 Smiths Medical
    • 6.1.9 Heine Optotechnik GmbH & Co. KG
    • 6.1.10 Eko Devices
    • 6.1.11 Meditech Equipment Co., Ltd.
    • 6.1.12 Contec Medical Systems

7 MARKET OPPORTUNITIES AND FUTURE TRENDS